Methadone used in the treatment of opioid dependency;Bruk av metadon i behandlingen av opioidavhengighet

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 2, 1999, Pages 237-241

  Waal, Helge ^a   Blix, Olof ^b   Krook, Aud ^c   Olsen, Harald ^d  

^a Senter Metadonassistert R   (Norway)

^b Stifteisen Bergensklinikkene   (Norway)

^c Senter Metadonassistert R   (Norway)

^d Psykofarmakologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE;

HEALTH CARE POLICY; HEROIN DEPENDENCE; HUMAN; METHADONE TREATMENT; NORWAY; OPIATE ADDICTION; REVIEW;

HEROIN DEPENDENCE; HISTORY, 20TH CENTURY; HUMANS; METHADONE; NORWAY; REGIONAL MEDICAL PROGRAMS; SOCIAL BEHAVIOR DISORDERS;

EID: 0033585574     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. St.meld. nr. 16 (1996-97). Narkotikapolitikken.
2. Waal H, Knutsen T, Welle-Strand G. Vedlikeholdsbehandling med metadon for HIV-smittede stoffmisbrukere med immunsvikt. Tidsskr Nor Lægeforen 1991: 111: 3083-6.
3. Welle-Strand G, Heger B, Lanesskog JO, Storksen P, Hoyland U, Flottorp S et al. Evalueringsrapport for prosjektet ≪Metadonbehandling av HIV-positive stoffmisbrukere med langtkommen immunsvikt≫. Oslo: Oslo kommune, 1992.
4. Skretting A. Evaluering av metadonprosjektet i Oslo. Del 1. Etablering, inntak av pasienter og forholdet til ovrige behandlingstiltak. SIFA-rapport nr. 4/97. Oslo: Statens institutt for alkoholog narkotikaforskning, 1997.
5. Ervik R. Evaluering av metadonprosjektet i Oslo. Del 2. Behandlingsforlop og status. SIFA-rapport nr. 5/97. Oslo: Statens institutt for alkohol- og narkotikaforskning, 1997.
6. Hauge R. Fra opiumskrig til legemiddelkontroll. Oslo: Rusmiddeldirektoratet, 1989.
7. McKim WA. Drugs and behavior. An introduction to behavioural pharmacology. New Jersey: Prenctice Hall, 1991.
8. Berridge V. British drug policy: a post-war situation? I: Waal H, red. Patterns on the European drug scene. An exploration of differences. Oslo: National Institute of Alcohol and Drug Research, 1998: 27-33.
9. Lowinson JH, Marion IJ, Herman JMA, Dole VP. Methadone maintenance. I: Lowinson JH, Ruiz P, Millman RB, Langrod JG, red. Substance abuse. A comprehensive textbook. 2. utg. Baltimore: Williams & Wilkins, 1992: 550-61.
10. Dole VP, Nyswander ME. A medical treatment for diacetyl-morphine (heroin) addiction. JAMA 1965; 193: 646.
11. Dole VP, Nyswander ME. Rehabilitation of heroin addicts after blockade with methadone. NY State J Med 1966; 66: 2011.
12. Goldstein A. Addiction - from biology to drug policy. New York: Freeman, 1994.
13. Iribarne C, Berthou F, Baird S, Dreano Y, Picart D, Bail JP, Beaune P, Minez JF. Involvement of cytochrom P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 1996; 9 (2): 365-73.
14. Inturissi CE, Veberly K. The levels of methadone in methadone maintenance. Clin Pharm Ther 1972, 13: 633-7.
15. Kreek M-J. A personal retrospective and prospective viewpoint. I: Parrino MPA. State Methadone Treatment Guidelines. Rockeville, MC: US Department of Health and Human Services, 1993: 133-43.
16. Holmstrand J, Gunne L-J, Wahlström A, Terenius L. CSF-Endorphins in heroin addicts during methadone maintenance and during withdrawal. Pharmacopsychiat 1981; 14: 126-8.
17. Vägverkets författningssamling VVFS 1996: 200.
18. Ruel J-M. International survey on the use of methadone in the treatment of narcotic addiction. Ottawa: Bureau of Drag Surveillance, 1996.
19. Waal H. Metadon til hvilket formal med hvilke etiske implikasjoner. Nordisk alkoholtidskrift 1996; 13: 275-80.
20. Blaine JD, red. Buprenorphine: an alternative treatment for opioid dependence. Research monograph 121. Rockville, MD: NIDA, 1992.
21. Strain EC, Stitzer ML, Liebson IA, Bieglow GE. Methadone dose and treatment outcome. Drug Alcohol Depend 1993; 33: 105-17.
22. Hermstad R, Johannesen G, Michelsen K. Hvilke effekter bar vedlikeholdsbehandling med metadon på rehabilitering av heroinavhengige? Tidsskr Nor Lægeforen 1998; 118: 3139-41.
23. Farrel M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D et al. Methadone maintenance in opioide dependence: a review. BMJ 1994; 300: 997-1001.
24. Anglin MD, McGlothlin WH. Outcome of narcotic addict treatment in California. I: Tims FM, Ludford JP, red. Drug abuse treatment evaluation: strategies, prospects and progress. Research monograph 51. Rockville, MD: NIDA, 1984.
25. Goldstein A, Harrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drag Alcohol Depend 1995; 40: 139-50.
26. Segest E, Mygind O, Bay H. The influence of prolonged stable methadone maintenance treat-ment on mortality and employment: an 8-year follow-up. Int J Addict 1990; 25: 53-63.
27. Arndt IO, McLelland T, Metzger D, Woody G, O'Brien C. Substitution treatment and psychological services. I: Rihs-Middel M. The medical prescription of narcotics. Scientific foundations and practical experiences. Seattle: Hogrefe & Huber, 1997.
28. Kreek MJ. Plasma and urine levels of methadone. NY State J Med 1973; 73: 1773-7.
29. Ball JC, Ross A. The effectiveness of methadone treatment: patients, programs, services and outcomes. New York: Springer, 1991.
30. Winslow J, Ege P. Metadon og hva så. København: Alkohol- og natkotikaraadet, 1983.
31. Stanton D, Todd TC. The family therapy of drug abuse and addiction. Guilford; New York, 1982.
32. Rounsaville BJ, Glazer W, Wilber CH, Weissman MM, Kleber HD. Short-term interpersonal psychotherapy in methadone-maintained opioide addicts. Arch Gen Psychiatry 1983; 40: 629-36.
33. Woody GE, McLelland T, Luborsky L, O'Brien C. Psychotherapy in community methad-one programs: a validation study. Am J Psychiatry 1995; 152: 1302-8.
34. Hagman G. A psychoanalyst in methadonia. J Subst Abuse Treat 1995; 12: 167-79.
35. Eklund C. Withdrawal from methadone maintenance treatment in Sweden. Doktoravhandling. Uppsala: Acta Universitatis Upsaliensis, 1996.
36. Teige B. Mortality - trends and registrations. I: Waal H, red. Patterns on the European drug scene. An exploration of differences. Oslo: Statens institutt for alkohol- og narkotikaforskning, 1998: 180-90.
37. Waal H. Introduction. I: Waal H (red). Patterns on the European drug scene. An exploration of differences. Oslo: Statens institutt for alkohol-og narkotikaforskning, 1998: 5-10.
38. Waal H. Drug use policies and HIV prevention - unhappy bedfellows? I: Waal H (red). Patterns on the European drug scene. An exploration of differences. Oslo: Statens institutt for alkohol-og narkotikaforskning 1998: 211-9.
39. Ministry of health, welfare and sports. Drugs policy in the Netherlands. Continuity and change. Hageman: Zoetermeer, 1995: 22.
40. Ege P. Metadonbehandling i Danmark: fra liberalisme til statlig styring. Stoffmisbruk 1996; 3: 29-30.
41. Grönbladh L, Gunne L. Methadone-assisted rehabilitation of Swedish heroin addicts. Drug Alcohol Depend 1989; 24: 31-7.
42. Waal H, red. Patterns on the European drug scene. An exploration of differences. Oslo: Statens institutt for alkohol- og narkotikaforskning, 1998: 211-9.